Disclosures for "An Efficient Approach to Mapping the Distribution of Renal Cell Carcinoma (RCC) Brain Metastases (BrM)")
-
The institution of Dr. Kamson has received research support from Maryland Cigarette Restitution Fund.
-
Mr. Feinaj has nothing to disclose.
-
Dr. Elias has nothing to disclose.
-
Mr. Yerrapragada has nothing to disclose.
-
Dr. Bettegowda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bionaut Labs. Dr. Bettegowda has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Rodey, Dickason, Sloan, Akin & Robb, P.A.. Dr. Bettegowda has stock in OrisDx. The institution of Dr. Bettegowda has received research support from NIH. Dr. Bettegowda has received intellectual property interests from a discovery or technology relating to health care.
-
Mr. Singla has nothing to disclose.
-
Yasser Ged has nothing to disclose.